Bliss GVS Pharma sees -7.73% dip in stock price, but remains a promising smallcap company

Bliss GVS Pharma Ltd, a smallcap pharmaceutical company, has seen a dip in its stock price by -7.73% on October 7th, 2024. Despite this recent decline, MarketsMOJO has given a 'Buy' call for the stock, as it is part of their Hidden Turnaround list since November 2nd, 2023.

In terms of performance, Bliss GVS Pharma has underperformed the sector by -6.27% today. The stock has also been on a consecutive fall for the last 3 days, with a total decline of -9.33% during this period. It reached an intraday low of Rs 120.55, showing a high volatility of 6.22% calculated from the weighted average price.

However, the stock's moving averages are still higher than the 100-day and 200-day moving averages, indicating a positive trend in the long term. On the other hand, it is currently lower than the 5-day, 20-day, and 50-day moving averages, suggesting a short-term decline.

In comparison to the Sensex performance, Bliss GVS Pharma has underperformed with a -7.46% return in the last 1 day and a -5.73% return in the last 1 month, while the Sensex has only seen a -1.06% and -0.45% return, respectively.

Despite the recent dip in stock price, Bliss GVS Pharma remains a promising smallcap company in the pharmaceutical industry. With a 'Buy' call from MarketsMOJO and a spot on their Hidden Turnaround list, investors can consider this stock for potential long-term growth.